Community-based case studies of vaccine hesitancy and the COVID-19 response in South Africa - study protocol
-
Published:2022-12-13
Issue:
Volume:11
Page:1514
-
ISSN:2046-1402
-
Container-title:F1000Research
-
language:en
-
Short-container-title:F1000Res
Author:
Wiysonge Charles SheyORCID,
Coulson Nancy,
Pillay Nirvana,
Cooper Sara,
Groenewald Candice,
Essack Zaynab,
Parker Saahier,
Houston Gregory,
Simmonds Jane,
Jaca Anelisa,
Mutemwa Muyunda,
Katoto Patrick DMC,
Rooyen Heidi van
Abstract
Background: In 2021 the South African government launched a large COVID-19 immunization campaign with the goal of reaching more than 40 million individuals. Nonetheless, certain international largely internet-based surveys at the time showed a significant proportion of vaccine hesitancy in South Africa. This study aims to determine and co-create with local stakeholders a comprehensive understanding of vaccine hesitancy and opportunities to support the promotion of other COVID-19 health-promoting behaviours at community level. Methods: A mixed-methods multiple case-study design; informed by the socio-ecological model of behaviour change. Four socio-economically diverse communities across South Africa will be selected and data collection will take place concurrently through three iterative phases. Phase 1 will provide insights into community experiences of COVID-19 (response) through desktop mapping exercises, observations, in-depth interviews, and focus group discussions (FGDs) designed as expression sessions with local stakeholders. Phase 2 will explore the extent and drivers of community acceptance of COVID-19 vaccines. This phase will comprise a survey based on WHO’s Behavioural and Social Drivers of Vaccination tool as well as further FGDs with community members. Phase 3 will involve cross-case study syntheses and presentation of findings to national role-players. Discussion: This study will provide ground up, locally responsive, and timeous evidence on the factors influencing COVID-19 health-seeking behaviours to inform ongoing management and mitigation of COVID-19 in South Africa. It will also provide insights into the applicability of a novel vaccine hesitancy model in Africa.
Funder
South African Medical Research Council
Human Sciences Research Council, South Africa
Publisher
F1000 Research Ltd
Subject
General Pharmacology, Toxicology and Pharmaceutics,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference41 articles.
1. The South African Response to the Pandemic.;S Abdool Karim;N. Engl. J. Med.,2020
2. National Department of Health, South Africa. Regulations and Relief.,2021 cited 2022 14 January 2022
3. National Department of Health, South Africa. Covid-19 Daily Updates & Cases.,2021 cited 2022 14 January 2022
4. New SARS-CoV-2 Variants - Clinical, Public Health, and Vaccine Implications.;S Abdool Karim;N. Engl. J. Med.,2021
5. The COVID-NMA Project: Building an Evidence Ecosystem for the COVID-19 Pandemic.;I Boutron;Ann. Intern. Med.,2020